SO
ATRA icon

STRS Ohio’s Atara Biotherapeutics ATRA Stock Holding History

STRS Ohio’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-184
Closed -$82.8K – 1896
2015
Q4 		$121K Hold
184
– – ﹤0.01% 1630
2015
Q3 		$144K Hold
184
– – ﹤0.01% 1592
2015
Q2 		$242K Buy
184
+92
+100% +$106K ﹤0.01% 1518
2015
Q1 		$95K Buy
92
+12
+15% +$7.93K ﹤0.01% 1617
2014
Q4 		$54K Buy
+80
New +$48.9K ﹤0.01% 1611

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's ATRA Position: Q1 2016 in Review

STRS Ohio sold out of Atara Biotherapeutics (ATRA) in Q1 2016, closing a stake of 184 shares — an estimated $82.8K sold.

STRS Ohio first reported a position in ATRA in Q4 2014 and held it in 5 quarters. The position peaked at $242K in Q2 2015. 71 funds tracked by Wall St. Rank hold ATRA as of Q1 2016.

  • STRS Ohio reported no remaining Atara Biotherapeutics position as of Q1 2016 after selling out during the quarter.
  • STRS Ohio sold 184 Atara Biotherapeutics shares in Q1 2016, an estimated $82.8K.
  • STRS Ohio first reported a position in Atara Biotherapeutics in Q4 2014 and held it in 5 quarters.
  • STRS Ohio's Atara Biotherapeutics position peaked at $242K in Q2 2015.
  • 71 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2016.

Based on STRS Ohio's 13F filing for Q1 2016, filed 21 Apr 2016.